These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 19291518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
    Tuomainen AM, Nyyssönen K, Laukkanen JA, Tervahartiala T, Tuomainen TP, Salonen JT, Sorsa T, Pussinen PJ.
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2722-8. PubMed ID: 17932311
    [Abstract] [Full Text] [Related]

  • 6. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
    Hurks R, Peeters W, Derksen WJ, Hellings WE, Hoefer IE, Moll FL, de Kleijn DP, Pasterkamp G.
    Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
    [Abstract] [Full Text] [Related]

  • 7. Biomarkers for cardiovascular disease: challenges and future directions.
    May A, Wang TJ.
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [Abstract] [Full Text] [Related]

  • 8. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.
    J Am Coll Cardiol; 2009 Aug 11; 54(7):601-8. PubMed ID: 19660689
    [Abstract] [Full Text] [Related]

  • 9. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA, Jones PH, Davidson MH.
    Am J Cardiol; 2008 Jun 16; 101(12A):41F-50F. PubMed ID: 18549871
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [What are the biomarkers of atherosclerosis and cardiovascular risk?].
    Riesen WF.
    Rev Med Suisse; 2008 Mar 12; 4(148):636-8, 640-3. PubMed ID: 18459658
    [Abstract] [Full Text] [Related]

  • 13. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG, Zacho J.
    Nutr Metab Cardiovasc Dis; 2009 Oct 12; 19(8):521-4. PubMed ID: 19695857
    [Abstract] [Full Text] [Related]

  • 14. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
    Woodward M, Tunstall-Pedoe H, Rumley A, Lowe GD.
    Br J Haematol; 2009 Aug 12; 146(4):442-6. PubMed ID: 19549268
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
    Rao M, Jaber BL, Balakrishnan VS.
    Semin Dial; 2006 Aug 12; 19(2):129-35. PubMed ID: 16551290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.